Screener
MoonLake Immunotherapeutics MLTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.71M-71.9% | -$63.02M-35.8% | -$70.69M-95.8% | -$56.05M-126% | -$40.56M-190% | ||
| $845K+124% | $751K+106% | $745K+112% | $742K+117% | $378K+15.2% | ||
| $13.36M+483% | $3.59M+85.6% | $3.71M+101% | $3.31M+81.0% | $2.29M+36.6% | ||
| -$66.29M-73.8% | -$58.79M-21.3% | -$44.54M-76.2% | -$54.53M-95.5% | -$38.14M-155% | ||
| $0-100% | —— | —— | —— | $35K-83.5% | ||
| $98K-99.8% | —— | $88.4M— | $88.25M+201% | $56.25M+295% | ||
| $24.47M-66.5% | —— | —— | —— | $73.02M— | ||
| $30.64M-58.1% | $72.4M+47,844% | $480K+162% | $0— | $73.12M+43.4% | ||
| -$36.03M-140% | —— | $44.06M— | $35.12M+130% | $91.14M+1,153% | ||
| -$66.29M-73.6% | -$58.79M-20.9% | -$44.54M-75.3% | -$54.53M-95.5% | -$38.18M-152% |
FAQ
- How much cash does MoonLake Immunotherapeutics generate?
- MoonLake Immunotherapeutics (MLTX) generated -$224.2M in operating cash flow over the trailing twelve months.
- What is MoonLake Immunotherapeutics's free cash flow?
- After $343.0K of capital expenditures, MoonLake Immunotherapeutics's free cash flow was -$224.2M over the trailing twelve months, down 60.0% year over year.
- Where does MoonLake Immunotherapeutics's cash flow data come from?
- Every line is extracted from MoonLake Immunotherapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.